Estimate Recalculated Nov 1, 2024 08:59AM EST
Joshua H. Bilenker has an estimated net worth of $72.7 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Gossamer Bio, Inc., ViewRay, Inc., Loxo Oncology, Inc., T2 Biosystems, Inc., and Roka BioScience, Inc..
Joshua H. Bilenker's CIK is 0001612312
2018 was Joshua H. Bilenker's most active year for acquiring shares with 29 total transactions. Joshua H. Bilenker's most active month to acquire stocks was the month of May. 2018 was Joshua H. Bilenker's most active year for disposing of shares, totalling 157 transactions. Joshua H. Bilenker's most active month to dispose stocks was the month of October. 2021 saw Joshua H. Bilenker paying a total of $500,000.00 for 62,295 shares, this is the most they've acquired in one year. In 2019 Joshua H. Bilenker cashed out on 1,452,151 shares for a total of $341,255,485.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!